{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-23-000119","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.359359+00:00","generated_at":"2026-06-08T09:17:36.439932+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MariMed Q3 revenue $38.8M (+14% YoY), GAAP net loss of $4.3M vs profit a year ago","bullets":["Revenue of $38.8M for Q3 2023, up 14% from $33.9M in Q3 2022.","GAAP net loss of $4.3M, compared to net income of $2.7M in the prior-year quarter.","Non-GAAP adjusted EBITDA of $6.1M (16% margin) vs $8.6M (25% margin) a year ago.","Reported 15th consecutive quarter of positive adjusted EBITDA.","Maryland adult-use sales launched July 1; wholesale business set quarterly records."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-23-000119","json":"https://secwatch.observer/filing/0001522767-23-000119.json","markdown":"https://secwatch.observer/filing/0001522767-23-000119.md","text":"https://secwatch.observer/filing/0001522767-23-000119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/mrmd-20231108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T09:17:36.439932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0008f2a2e41df62bde6f74b91d5fe596e6937db6","claim":"MARIMED INC. reported three months ended September 30, 2023 results: revenue $ 38.8, net income $ (4.3).","evidence_excerpt":"Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022 Revenue $ 38.8 $ 33.9 $ 109.7 $ 98.2 GAAP Gross margin 43 % 48 % 44 % 49 % Non-GAAP Gross margin 45 % 48 % 45 % 49 % GAAP Net (loss) income $ (4.3) $ 2.7 $ (5.9) $ 8.9 Non-GAAP Net (loss) income $ (3.1) $ 4.7 $ (2.2) $ 17.0 Non-GAAP Adjusted EBITDA $ 6.1 $ 8.6 $ 19.4 $ 27.9 Non-GAAP Adjusted EBITDA margin 16 % 25 % 18 % 28 %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended September 30, 2023"},{"label":"Revenue","value":"$ 38.8"},{"label":"Net income","value":"$ (4.3)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d5c910ce506d3578a6e2bf1658c253f82ecdc9b2","claim":"MARIMED INC. reported nine months ended September 30, 2023 results: revenue $ 109.7, net income $ (5.9).","evidence_excerpt":"Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022 Revenue $ 38.8 $ 33.9 $ 109.7 $ 98.2 GAAP Gross margin 43 % 48 % 44 % 49 % Non-GAAP Gross margin 45 % 48 % 45 % 49 % GAAP Net (loss) income $ (4.3) $ 2.7 $ (5.9) $ 8.9 Non-GAAP Net (loss) income $ (3.1) $ 4.7 $ (2.2) $ 17.0 Non-GAAP Adjusted EBITDA $ 6.1 $ 8.6 $ 19.4 $ 27.9 Non-GAAP Adjusted EBITDA margin 16 % 25 % 18 % 28 %","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2023"},{"label":"Revenue","value":"$ 109.7"},{"label":"Net income","value":"$ (5.9)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}